-
1 Comment
The Supreme Cannabis Company, Inc is currently in a long term uptrend where the price is trading 32.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
The Supreme Cannabis Company, Inc's total revenue rose by 102.1% to $18M since the same quarter in the previous year.
Its net income has increased by 54.3% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 97.9% to $-778K since the same quarter in the previous year.
Based on the above factors, The Supreme Cannabis Company, Inc gets an overall score of 5/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers-Specialty & Generic |
Exchange | TO |
ISIN | CA86860J1066 |
CurrencyCode | CAD |
Dividend Yield | 0.0% |
---|---|
Market Cap | 256M |
Target Price | 0.48 |
PE Ratio | None |
Beta | 2.22 |
The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FIRE.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024